For citations:
Kniajeskaia NP, Safoshkina EV, Kameleva AA, Belevsky AS, Anaev EK. Omalizumab as the first drug of genetically engineered biological therapy: New expectations and relevance of use in bronchial asthma. Meditsinskiy sovet = Medical Council. 2024;(13):92-98. (In Russ.) https://doi.org/10.21518/ms2024-249